David A. Schwartz
Dr Schwartz discusses his presentation on the evaluation and management of perianal fistulizing Crohn's disease from the ACG Scientific Meeting, including review of results from studies of guselkumab, upadacitinib, and vedolizumab as...
Dr Schwartz discusses his presentation on the evaluation and management of perianal fistulizing Crohn's disease from the ACG Scientific Meeting, including review of results from studies of guselkumab, upadacitinib, and vedolizumab as...
Dr Schwartz discusses his...